革命性淋巴结转移成像:药物输送系统的作用和未来的前景
Ze-Min Cai1, Zi-Zhan Li1, Nian-Nian Zhong1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430072, China.
Journal of nanobiotechnology
|March 30, 2024
概括
控制药物递送系统 (DDS) 通过克服传统方法的局限性,为增强淋巴结转移 (LNM) 成像提供了一个有希望的解决方案. 本综述探讨了用于提高LNM检测诊断精度的DDS应用.
科学领域:
- 医疗成像医学成像
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 图像检查对于诊断淋巴结转移 (LNM) 是至关重要的.
- 技术进步已经为LNM检测引入了各种各样的成像技术.
- 传统的成像剂的使用方法有缺点和副作用.
研究的目的:
- 审查药物输送系统 (DDS) 在转移性淋巴结 (LN) 成像中的历史背景和当前应用.
- 讨论使用LNM的DDS进行诊断和治疗功能的整合.
- 探索LNM成像中DDS的未来前景和发展轨迹.
主要方法:
- 对LNM的成像技术进行全面的文献综述.
- 分析与成像方式结合使用的各种DDS.
- 讨论使用DDS的诊断和治疗策略的融合.
主要成果:
- DDS显示出克服传统成像剂的局限性的潜力.
- 整合DDS可以提高转移性LN成像中的诊断精度.
- DDS 允许结合 LNM 的诊断和治疗方法.
结论:
- 药物输送系统代表了转移性淋巴结成像的重大进步.
- 未来的DDS开发有望改善LNM检测和管理.
- DDS与先进的成像技术的协同作用是未来进步的关键.
相关概念视频
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.7K
Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Cellular Membranes and Drug Transport
2.1K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.1K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
2.5K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
2.5K
Carrier-Mediated Transport
1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164


